This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Bosentan

Read time: 1 mins
Marketing start date: 23 Dec 2024
...
 

Summary of product characteristics


Effective Time

20230920

Version

5

Spl Product Data Elements

Bosentan Bosentan BOSENTAN BOSENTAN ANHYDROUS ETHYLCELLULOSE, UNSPECIFIED FERRIC OXIDE RED FERRIC OXIDE YELLOW GLYCERYL DIBEHENATE HYPROMELLOSE, UNSPECIFIED MAGNESIUM STEARATE POVIDONE SODIUM STARCH GLYCOLATE TYPE A POTATO STARCH, CORN TALC TITANIUM DIOXIDE TRIACETIN LIGHT PINK BICONVEX 446 Bosentan Bosentan BOSENTAN BOSENTAN ANHYDROUS ETHYLCELLULOSE, UNSPECIFIED FERRIC OXIDE RED FERRIC OXIDE YELLOW GLYCERYL DIBEHENATE HYPROMELLOSE, UNSPECIFIED MAGNESIUM STEARATE POVIDONE SODIUM STARCH GLYCOLATE TYPE A POTATO STARCH, CORN TALC TITANIUM DIOXIDE TRIACETIN LIGHT PINK BICONVEX 447

Application Number

ANDA207760

Brand Name

Bosentan

Generic Name

Bosentan

Product Ndc

70771-1017

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1017-6 Bosentan tablets, 62.5 mg 60 tablets Rx only NDC 70771-1018-6 Bosentan tablets, 125 mg 60 tablets Rx only Bosentan tablets Bosentan tablets

Spl Medguide

SPL MEDGUIDE

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.